308 related articles for article (PubMed ID: 24821914)
21. A systems approach to infectious disease.
Eckhardt M; Hultquist JF; Kaake RM; Hüttenhain R; Krogan NJ
Nat Rev Genet; 2020 Jun; 21(6):339-354. PubMed ID: 32060427
[TBL] [Abstract][Full Text] [Related]
22. Detecting specific infections in children through host responses: a paradigm shift.
Mejias A; Suarez NM; Ramilo O
Curr Opin Infect Dis; 2014 Jun; 27(3):228-35. PubMed ID: 24739346
[TBL] [Abstract][Full Text] [Related]
23. System-wide coordinates of higher order functions in host-pathogen environment upon Mycobacterium tuberculosis infection.
Parvati Sai Arun PV; Miryala SK; Rana A; Kurukuti S; Akhter Y; Yellaboina S
Sci Rep; 2018 Mar; 8(1):5079. PubMed ID: 29567998
[TBL] [Abstract][Full Text] [Related]
24. Metagenomics: A New Way to Illustrate the Crosstalk between Infectious Diseases and Host Microbiome.
Zhang Y; Lun CY; Tsui SK
Int J Mol Sci; 2015 Nov; 16(11):26263-79. PubMed ID: 26540050
[TBL] [Abstract][Full Text] [Related]
25. Clinical applications of bacterial glycoproteins.
Fulton KM; Smith JC; Twine SM
Expert Rev Proteomics; 2016; 13(4):345-53. PubMed ID: 26971465
[TBL] [Abstract][Full Text] [Related]
26. Tackling antibiotic resistance in India.
Wattal C; Goel N
Expert Rev Anti Infect Ther; 2014 Dec; 12(12):1427-40. PubMed ID: 25353717
[TBL] [Abstract][Full Text] [Related]
27. A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm.
Aderem A; Adkins JN; Ansong C; Galagan J; Kaiser S; Korth MJ; Law GL; McDermott JG; Proll SC; Rosenberger C; Schoolnik G; Katze MG
mBio; 2011 Mar; 2(1):e00325-10. PubMed ID: 21285433
[TBL] [Abstract][Full Text] [Related]
28. Surveillance for antimicrobial drug resistance in under-resourced countries.
Vernet G; Mary C; Altmann DM; Doumbo O; Morpeth S; Bhutta ZA; Klugman KP
Emerg Infect Dis; 2014 Mar; 20(3):434-41. PubMed ID: 24564906
[TBL] [Abstract][Full Text] [Related]
29. Host Transcriptomics as a Tool to Identify Diagnostic and Mechanistic Immune Signatures of Tuberculosis.
Burel JG; Babor M; Pomaznoy M; Lindestam Arlehamn CS; Khan N; Sette A; Peters B
Front Immunol; 2019; 10():221. PubMed ID: 30837989
[TBL] [Abstract][Full Text] [Related]
30. Systems biology of pathogen-host interaction: networks of protein-protein interaction within pathogens and pathogen-human interactions in the post-genomic era.
Durmuş Tekir SD; Ülgen KÖ
Biotechnol J; 2013 Jan; 8(1):85-96. PubMed ID: 23193100
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial drug resistance: a danger to world health.
Dugger B
J Intraven Nurs; 1997; 20(2):101-8. PubMed ID: 9104205
[TBL] [Abstract][Full Text] [Related]
32. Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy.
Bloom CI; Graham CM; Berry MP; Wilkinson KA; Oni T; Rozakeas F; Xu Z; Rossello-Urgell J; Chaussabel D; Banchereau J; Pascual V; Lipman M; Wilkinson RJ; O'Garra A
PLoS One; 2012; 7(10):e46191. PubMed ID: 23056259
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA molecules in tuberculosis.
Fathizadeh H; Hayat SMG; Dao S; Ganbarov K; Tanomand A; Asgharzadeh M; Kafil HS
Int J Biol Macromol; 2020 Aug; 156():340-346. PubMed ID: 32283111
[TBL] [Abstract][Full Text] [Related]
34. Transcriptomics: the key to biomarker discovery during tuberculosis?
van Rensburg IC; Loxton AG
Biomark Med; 2015; 9(5):483-95. PubMed ID: 25985177
[TBL] [Abstract][Full Text] [Related]
35. The current state of infectious disease: a clinical perspective on antimicrobial resistance.
Shay LE; Freifeld AG
Lippincotts Prim Care Pract; 1999; 3(1):1-15; quiz 16-8. PubMed ID: 10214199
[TBL] [Abstract][Full Text] [Related]
36. Transfer transcriptomic signatures for infectious diseases.
di Iulio J; Bartha I; Spreafico R; Virgin HW; Telenti A
Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34031243
[TBL] [Abstract][Full Text] [Related]
37. Emerging infectious diseases: public health issues for the 21st century.
Binder S; Levitt AM; Sacks JJ; Hughes JM
Science; 1999 May; 284(5418):1311-3. PubMed ID: 10334978
[TBL] [Abstract][Full Text] [Related]
38. Infection systems biology: from reactive to proactive (P4) medicine.
Bengoechea JA
Int Microbiol; 2012 Jun; 15(2):55-60. PubMed ID: 22847266
[TBL] [Abstract][Full Text] [Related]
39. Using a Systems Biology Approach To Study Host-Pathogen Interactions.
Yeung A; Hale C; Clare S; Palmer S; Bartholdson Scott J; Baker S; Dougan G
Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30953425
[TBL] [Abstract][Full Text] [Related]
40. Systems biology of infectious diseases: a focus on fungal infections.
Santamaría R; Rizzetto L; Bromley M; Zelante T; Lee W; Cavalieri D; Romani L; Miller B; Gut I; Santos M; Pierre P; Bowyer P; Kapushesky M
Immunobiology; 2011 Nov; 216(11):1212-27. PubMed ID: 21889228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
